Buy Heroin Puebla

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buy Heroin Puebla

This operation completely dismantles an organization dedicated to the introduction of cocaine into Spain from Colombia, impregnated in cardboard boxes for the transport of fruit and its subsequent transformation in a clandestine laboratory. One of the branches of the organisation was responsible for introducing drugs into the port of Malaga using a fruit company as a front. The other branch, run by the family of a former Colombian hitman, was responsible for transforming the drug in a clandestine laboratory. The members of the network introduced the shipment of bananas into the port of Malaga inside cardboard boxes contaminated with narcotic substances, which they then took to a warehouse where they exchanged the impregnated boxes for others, to later proceed to sell the fruit and thus simulate the commercial activity that served as a front. Specifically, in Toledo 13 , Madrid 8 , Malaga 5 and Colombia 2 and searches have been carried out in Madrid 8 , Toledo 5 and Malaga 4 , in which 47 kilos of cocaine, 20 kilos of cocaine base, 3, liters of liquid precursors and kilos of solids, three firearms, 20 vehicles and more than , euros in cash have been seized. August 25, Specifically, 28 people have been arrested, spread across Toledo 13 , Madrid 8 , Malaga 5 and Colombia 2 and searches have been carried out in Madrid 8 , Toledo 5 and Malaga 4 , in which 47 kilos of cocaine, 20 kilos of cocaine base, 3, litres of liquid precursors and kilos of solids, three firearms, 20 vehicles and more than , euros in cash have been seized. The investigation began in August when police officers received information from the Liaison Officer of the Spanish National Police in Colombia, reporting the possible contamination of a container bound for the port of Malaga, operated by two companies - one exporter and one importer - related to the fruit trade. The agents then began an investigation into the fruit import company, based in Malaga. As a result of these efforts, they were able to discover that this organization had met, on several occasions, with the sons of a former Colombian hitman, head of a 'collection office' that sold its services to Colombian cartels established in our country. In recent years, this man had transformed his business of collecting money and contract killing into a powerful organisation for introducing and distributing cocaine in Spain. The members of this family were settled in Madrid and Toledo and had a large number of properties, safe houses, companies, vehicles and a large group of people at their disposal. The agents were able to observe that the organization operated like a mafia family, highlighting its secrecy and perfect hierarchy among all its members. The head of the family transmitted the instructions to the highest ranking members, who were his own children and his nephew who came from Colombia, so that they would spread them to the lower levels, in charge of the most exposed tasks, such as transporting narcotic substances and money obtained from their sale. At one point during the investigation, agents detected the arrival at the port of Malaga of a container from Colombia, containing a shipment of bananas in contaminated cardboard boxes. Members of the Malaga branch of the organization, owners of the import company, rented an industrial warehouse in a small town, where they proceeded to replace the boxes that had been impregnated with cocaine with new ones. For this task, they hired a team that spent three days doing this work, under the orders of the main suspects and spending the night in a nearby farm, completely isolated from the outside. Once the members of the organization in Madrid received the drugs, they began a constant activity, since they had to receive those in charge of extracting and processing the drugs, who came to our country for a short period of time, just the time necessary for the extraction of the drugs. One of these men was an experienced 'drug cook' who had worked for the 'Clan del Golfo' where he directed monthly productions of four tons of drugs. The property that housed the laboratory had an olive grove, a livestock farm and a bullring. In that bullring, specifically in the lower part of the stands, the laboratory was installed, which was divided into various areas, each of them with a specific purpose and which, together, made it possible to produce a large quantity of narcotics. With the establishment of this laboratory, the organization intended to create a continuous production line in our country, for which they used equipment similar to that used in the large laboratories in Colombia. On June 5, the raid on the laboratory was carried out with the support of the Special Operations Group GEO , where the drugs had already been packaged in blocks or 'bricks' of one kilogram of cocaine hydrochloride. Agents intercepted two vehicles that were leaving the laboratory at that time, one of them, driven by the clan's eldest son, was transporting 21 kilos of newly manufactured cocaine ready to be manufactured. In this first phase, the agents arrested 18 people, 11 of whom were related to the police. During the searches, more than , euros, 26 kilos of cocaine hydrochloride, 13 vehicles, two firearms and 20 kilos of cocaine base, ready to be processed into cocaine hydrochloride, were seized. In Madrid, six homes and a storage room were searched, including the one belonging to the leader's son, where two pistols and more than , euros in vacuum-packed cash were found. On the other hand, 26 kilos of cocaine hydrochloride ready for sale were hidden in the flat of a member of the organisation, bearing the same logo as those found in the laboratory. The rest of the houses were used by collaborators of the dismantled organization. On June 28, a second phase of exploitation was carried out in the provinces of Malaga and Madrid, in which eight people of Colombian, Chilean and Spanish origin, residents of Malaga and Madrid, were arrested. They were responsible for introducing the drug into Spain from Colombia, using fruit import companies, as well as handling and delivering the contaminated cartons at source to those responsible for their extraction and final sale. To close the circle on all the strata of this international criminal organization, the National Court issued various International Arrest Warrants for the arrest of several of the main members of the supplier organization in Colombia. In July and August, Colombian National Police agents arrested two key individuals in the organization, providing infrastructure, route configuration and methods of shipping cocaine to our country. In both operations, Europol supported the operation, sending an expert with the most advanced computer equipment to upload relevant information for the investigations. With these arrests and searches, a major criminal organization responsible for smuggling large quantities of cocaine has been completely dismantled. Agents from the National Police, with the support of Europol, carried out this joint operation in collaboration with the Colombian authorities and in line with the European Union Security Strategy. This strategy focuses on four key points: establishing a future-proof security environment, combating emerging threats, protecting European citizens from terrorism and organised crime, and forging a robust European security ecosystem. The interventions carried out under this scheme have been co-financed by the European Union, as part of the support to Member States to combat criminal networks that constitute the most significant threats to the security of EU citizens and the Union as a whole.

Journal of Illicit Economies and Development

Buy Heroin Puebla

Official websites use. Share sensitive information only on official, secure websites. Goodman-Meza and D. Werb conceptualized the idea for the article. Goodman-Meza conducted the literature review and evidence collection and wrote the initial draft. Medina-Mora and C. Werb, R. Landovitz, and S. Shoptaw critically revised the article. All authors contributed to the editing and final approval of the article. In North America, opioid use and its harms have increased in the United States and Canada over the past 2 decades. However, Mexico has yet to document patterns suggesting a higher level of opioid use or attendant harms. Historically, Mexico has been a country with low-level use of opioids, although heroin use has been documented. Low-level opioid use is likely attributable to structural, cultural, and individual factors. However, a range of dynamic factors may be converging to increase the use of opioids: legislative changes to opioid prescribing, national health insurance coverage of opioids, pressure from the pharmaceutical industry, changing demographics and disease burden, forced migration and its trauma, and an increase in the production and trafficking of heroin. In addition, harm-reduction services are scarce. Mexico may transition from a country of low opioid use to high opioid use but has the opportunity to respond effectively through a combination of targeted public health surveillance of high-risk groups, preparation of appropriate infrastructure to support evidence-based treatment, and interventions and policies to avoid a widespread opioid use epidemic. Furthermore, continental drug trafficking patterns and similar approaches to opioid prescribing suggest that the current opioid use epidemic has likely been similar in the United States and Canada because of cultural and prescribing similarities. Curiously, Mexico has yet to document patterns suggestive of a national trend toward higher levels of opioid use Table 1. This has been largely related to its role as a transit and production country from which illicit drugs are trafficked to the United States, the ensuing violence associated with domestic efforts to disrupt this traffic, 11 and a high prevalence of injection drug use at its northern border and along drug trafficking routes leading into the United States. For the purpose of this essay, we define the opioid use epidemic as a rapid increase in the use of prescription and nonprescription opioids leading to intentional and unintentional harms i. We propose this definition to assess the risk that Mexico will experience its own opioid use epidemic and investigate strategies to mitigate these risks. Historically, Mexico has been a country with a low prevalence of substance use, with alcohol by far the substance most commonly used. The highest prevalence of heroin use occurred in men aged between 18 and 34 years, reaching 0. Heroin use in this region has been associated with economic disadvantage, sex work, internal displacement, and the presence of drug-trafficking routes. However, heroin use was also detected in states in the interior and south of the country, namely Morelos, Puebla, Guerrero, and Oaxaca. Misuse of prescription opioids in Mexico has been low. In , morphine was first regulated in Mexico. Since the s, several efforts by the World Health Organization WHO and national palliative care advocacy groups had failed to increase coverage of opioid analgesics in the Mexican market. Before , limits on the prescribed use of opioids in Mexico were largely attributable to legislative restrictions, which were extensive in comparison with those in the other North American countries. Another structural barrier had been the cost of opioids. For example, in , it was reported that a monthly supply of opioid therapy could cost more than twice the mean monthly salary in Mexico. However, a survey on risk perceptions of analgesics undertaken among more than medical students and residents reported morphine as being perceived as the riskiest, with its potential for addiction of highest concern. Nonetheless, a systematic review from the United States suggested that Hispanic American patients noted concerns about using strong pain medications, like opioids, and were more likely to use stoicism, religious coping, and catastrophizing, while also preferring nonpharmacologic treatments for pain though this review was not specific to Mexican Americans. These changes and their potential impacts in promoting an opioid use epidemic are summarized in the next sections. In , the structural barriers reported previously were highlighted in a report by Human Rights Watch, which stated that the lack of training for medical providers, their difficulties in prescribing opioids, and patient barriers to accessing palliative care services left many terminally ill patients needlessly in pain. In the United States, as the harms of opioid use have become increasingly widespread, the Food and Drug Administration requested that the highly addictive oral opioid oxymorphone hydrochloride Opana ER, Endo Pharmaceuticals be removed from the formulary, 38 while various states have initiated legal action against Purdue Pharma the maker of OxyContin and others for their role in contributing to the ensuing opioid overdose epidemic. As the population ages in Mexico, diseases linked to aging are more common. In , the 5 leading causes of disease burden in the country were chronic diseases: diabetes, ischemic heart disease, chronic kidney disease, low back and neck pain, and depressive disorders. Given the aging population in Mexico, it might be argued that traditional cultural beliefs that have limited opioid use may persist; nonetheless, the increased need for pain medication caused by chronic diseases may precipitate a change in beliefs, and lobbying by the pharmaceutical industry and increasing ease of prescribing may change beliefs at the provider level. Changes in attitudes toward opioids tied with structural factors opening up opioid prescribing may tilt the balance toward an epidemic. Deportation has been identified as a key risk factor for heroin injecting along the US—Mexico border. In a review of the effect of forced migration on substance use, Horyniak et al. The increase in Mexican production and trafficking of heroin has been accompanied by expanded use within the country. Given these factors, we note the real possibility of a widespread opioid use epidemic in Mexico in the coming years, particularly as the population ages. Mexico has the chance to mitigate the risks of widespread opioid use and their related complications see the box on page Because of the previous inaccessibility of opioids and low prescribing, Mexican providers e. Evidence-based prescribing methods are being adopted and tested in the United States 75—77 and could be tailored for Mexican providers. Furthermore, future generations of clinicians should receive this training during medical school education. Of concern, Mexico largely remains without access to key interventions that could limit potential opioid-related morbidity and mortality, such as adequate medication-assisted treatment MAT; e. Mexico could also implement or expand a variety of harm-reduction strategies that have been shown to reduce potential opioid-related harm or risk behavior. These include syringe distribution services, improving the interface of law enforcement and people who use drugs, provision of naloxone, and medically supervised injection facilities. Syringe distribution services have been implemented and found to be cost-effective in Mexico, 89 although these are limited to major cities, 85,90 and considerable stigma exists in Mexico regarding the purchase of syringes from commercial pharmacies. Finally, supervised injection facilities where PWID can use heroin or other drugs with sterile equipment under medical supervision have demonstrated health and cost savings in analyses undertaken in cities including Vancouver, Canada, 97 and Sydney, Australia. Mexico faces unique vulnerabilities given its geographic location, changing population demographics, and population disease burden, all of which place it at great risk of a widespread opioid use epidemic similar to that of the United States and Canada. The intersection of a fragile emerging social structure as a result of nationals returning through deportation from the United States; structural challenges in the treatment of pain; lobbying from pharmaceutical companies; increasing local production, distribution, and availability of heroin; and a lack of infrastructure to support evidence-based treatment of opioid use disorder are likely to increase the risk of a generalized Mexican opioid use epidemic. Nevertheless, previous examples of increased usage in settings with increased domestic availability of opioids as a result of international drug trafficking suggest that a grave risk exists that the combination of expanded access to prescribed opioids and local heroin production may lead Mexico past the threshold for an opioid use epidemic. Mexico has the opportunity to respond effectively through a combination of targeted public health surveillance of high-risk groups, preparation of appropriate infrastructure to support evidence-based treatment, and interventions and policies to avoid a fate similar to that of its neighbors. Externally, Mexico is likely to face political pressure from the United States if it moves to enact formal regulation of currently illegal drugs and will also face concerns regarding reconciling this policy decision with its role as a signatory to the United Nations conventions on drugs as have other countries such as Canada in the wake of cannabis legalization. When one considers the high levels of human mobility among Mexico, the United States, and Canada, there is a shared continental responsibility to champion efforts to reduce the ongoing burden of preventable opioid-related morbidity and mortality. As US drug policy will likely continue to earmark aid toward supply reduction and military counternarcotics campaigns south of the US—Mexico border, Mexico should negotiate support for harm reduction and substance use treatment within its borders to accompany any such aid. Other collaborations could entail capacity building for providers in the areas of the prevention and management of chronic pain-causing conditions and provision of MAT. Finally, if and when new, safer medical drugs for treatment of pain or substance use come to market, preferential drug prices for Mexico should be negotiated and made available. Shoptaw and R. We are also grateful to the anonymous reviewers who provided suggestions to further strengthen the article. No human participants were part of this research. Institutional review board approval was not necessary. As a library, NLM provides access to scientific literature. Am J Public Health. Raphael J. Find articles by David Goodman-Meza. Find articles by Maria Elena Medina-Mora. Find articles by Raphael J Landovitz. Find articles by Steve Shoptaw. Find articles by Dan Werb. Accepted Sep 9; Issue date Jan. Open in a new tab. See also Palinkas, p. Similar articles. Add to Collections. Create a new collection. Add to an existing collection. Choose a collection Unable to load your collection due to an error Please try again. Add Cancel. Prescribing based on evidence-based conditions and only when nonpharmacologic therapies and other analgesics have been tried. Evidence-based early detection and treatment programs e.

Buy Heroin Puebla